Palatin Technologies, Inc. (PTN)
NYSEAMERICAN: PTN · IEX Real-Time Price · USD
1.730
+0.020 (1.17%)
At close: Jul 19, 2024, 4:00 PM
1.740
+0.010 (0.58%)
Pre-market: Jul 22, 2024, 6:46 AM EDT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of $27.92 million as of July 22, 2024. Its market cap has increased by 13.02% in one year.
Market Cap
27.92M
Enterprise Value
18.61M
1-Year Change
13.02%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since December 1, 1998, Palatin Technologies's market cap has decreased from $9.13B to $27.92M, a decrease of -99.69%. That is a compound annual growth rate of -20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 27.90M | -48.99% |
| Dec 29, 2023 | 54.70M | 106.42% |
| Dec 30, 2022 | 26.50M | -77.62% |
| Dec 31, 2021 | 118.40M | -23.81% |
| Dec 31, 2020 | 155.40M | -13.28% |
| Dec 31, 2019 | 179.20M | 24.53% |
| Dec 31, 2018 | 143.90M | -11.99% |
| Dec 29, 2017 | 163.50M | 199.45% |
| Dec 30, 2016 | 54.60M | 20.80% |
| Dec 31, 2015 | 45.20M | 56.94% |
| Dec 31, 2014 | 28.80M | - |
| Dec 31, 2013 | 28.80M | 23.08% |
| Dec 31, 2012 | 23.40M | 67.14% |
| Dec 30, 2011 | 14.00M | -12.50% |
| Dec 31, 2010 | 16.00M | -54.93% |
| Dec 31, 2009 | 35.50M | 355.13% |
| Dec 31, 2008 | 7.80M | -54.12% |
| Dec 31, 2007 | 17.00M | -88.28% |
| Dec 29, 2006 | 145.10M | -24.27% |
| Dec 30, 2005 | 191.60M | 33.43% |
| Dec 31, 2004 | 143.60M | -96.87% |
| Dec 31, 2002 | 4.59B | -52.86% |
| Dec 31, 2001 | 9.73B | 24.44% |
| Dec 29, 2000 | 7.82B | 35.00% |
| Dec 31, 1999 | 5.79B | -39.47% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Streamline Health Solutions | 29.15M |
| Akari Therapeutics, | 29.07M |
| Surrozen | 28.79M |
| bioAffinity Technologies | 28.56M |
| Enlivex Therapeutics | 28.28M |
| Bolt Biotherapeutics | 27.87M |
| RenovoRx | 27.78M |
| Brainstorm Cell Therapeutics | 27.56M |